Actinic Keratosis Diagnosis Ups Cumulative Risk for Skin Cancer
MONDAY, March 29, 2021 -- The annual increase in risk for cutaneous squamous cell carcinoma (cSCC) is higher for patients who have received a diagnosis of one or more actinic keratoses (AKs), according to a study published online March 24 in JAMA Dermatology.
Shabnam Madani, M.D., from Kaiser Permanente in Walnut Creek, California, and colleagues followed 220,236 patients with AK and 220,236 matched controls to assess the 10-year incidence of cSCC.
The researchers found that the risk for cSCC increased with each year of follow-up by 1.92 percent in patients with AK and by 0.83 percent in matched control patients (hazard ratio, 1.90). However, risk was substantially greater among patients aged 49 years and younger diagnosed with AK (hazard ratio, 6.77). The cumulative incidence of cSCC reached 17.1 percent at 10 years among patients with AK and 5.7 percent in control patients. There was a modest association observed between increased numbers of AKs and increased cSCC risk (≥15 AKs versus one AK: hazard ratio, 1.89). Risk factors for cSCC, other than AK, included older age, White race (a proxy for skin type), history of basal cell carcinoma, and male sex.
"These results can be used to develop recommendations for risk-based patient education, treatment, and surveillance," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
FRIDAY, April 16, 2021 -- Chronic immune-related adverse effects after adjuvant treatment with anti-programmed cell death 1 (anti-PD-1) immunotherapies for melanoma are more...
MONDAY, April 12, 2021 -- A tanning bed ban for U.S. minors would be cost-effective, according to a study published online April 12 in Cancer. Antoine Eskander, M.D., from the...
MONDAY, April 12, 2021 -- Higher exposure to thiazides is associated with increased rates of incident keratinocyte carcinoma and melanoma among older adults, according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.